Company: SMNR
Filing Date: 2025-04-09
Form Type: 425
Source: 0001213900-25-030050
Chunk: 3

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-09
Form: 425
Chunk 3
---
 update any forward-looking statements to reflect changes in information, events or circumstances
after the date of this report, except as required by law.

<div align='center'>1

SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: April 8, 2025 | DENALI CAPITAL ACQUISITION CORP. 
 By:                              | /s/ Lei Huang           |
|:--------------------|:---------------------------------|:------------------------|
|                     | Name:                            | Lei Huang               |
|                     | Title:                           | Chief Executive Officer |

<div align='center'>2</div>